Early Peanut Introduction Strategy Reduces Childhood Allergies—But Why Is Washington Slow to Act?
A decade after a groundbreaking study, early peanut exposure to infants has sharply cut allergy rates, yet confusion and slow medical adoption illustrate a broader failure in turning scientific breakthroughs into public health victories under current leadership.

For too long, American families suffered under outdated medical advice that delayed exposing babies to peanuts, inadvertently fueling a rise in dangerous allergies. Now, new research reveals that early introduction of peanut products to infants has averted peanut allergies in approximately 60,000 children since 2015. This breakthrough, rooted in the landmark LEAP trial, demonstrates how a simple shift in practice could safeguard countless young Americans from life-threatening reactions. Why Did It Take So Long to Adopt Proven Practices? The LEAP study, led by Dr. Gideon Lack in 2015, shocked the medical community by showing that introducing peanut products to babies...
This is Exclusive Content for Subscribers
Join our community of patriots to read the full story and get access to all our exclusive analysis.
View Subscription Plans